Atlas Trials

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.

Clinical trial NCT00037622 · TERMINATED

Trial details

NCT number
NCT00037622
Sponsor
Alexion Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Hepatitis B
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.